Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Buy
1,948
+5
+0.3% +$1.71K 0.56% 47
2026
Q1
$684K Buy
1,943
+28
+1% +$9.98K 0.61% 45
2025
Q4
$627K Sell
1,915
-5
-0.3% -$1.59K 0.56% 46
2025
Q3
$542K Sell
1,920
-234
-11% -$67.9K 0.5% 49
2025
Q2
$602K Buy
2,154
+188
+10% +$53.3K 0.59% 44
2025
Q1
$606K Sell
1,966
-55
-3% -$16.2K 0.59% 47
2024
Q4
$572K Buy
+2,021
New +$600K 0.55% 49

Other funds holding AMGN

Roxbury Financial's AMGN Position: Q2 2026 in Review

Roxbury Financial increased its Amgen (AMGN) stake by 0.26% in Q2 2026, buying an estimated $1.71K and bringing the position to 1,948 shares worth $705K. The position accounts for 0.56% of the portfolio, ranked #47.

Roxbury Financial first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Roxbury Financial held 1,948 shares of Amgen worth $705K as of Q2 2026.
  • Roxbury Financial bought 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up 0.56% of Roxbury Financial's portfolio in Q2 2026, its #47 holding.
  • Roxbury Financial first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.